UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$365M |
| 2 |
Trane Technologies
TT
|
+$207M |
| 3 |
TC Energy
TRP
|
+$163M |
| 4 |
Merck
MRK
|
+$158M |
| 5 |
Walt Disney
DIS
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$210M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$196M |
| 3 |
Johnson & Johnson
JNJ
|
+$190M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$180M |
| 5 |
Meta Platforms (Facebook)
META
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.31% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
KBR
KBR
$4.68B
| $3.92M | ﹤0.01% |
157,146
+7,297
| +5% | +$163K |
|
1252
Collegium Pharmaceutical
COLL
$1.04B
| $3.91M | ﹤0.01% |
297,712
-5,936
| -2% | -$79.4K |
|
1253
Silicon Laboratories
SLAB
$7.21B
| $3.91M | ﹤0.01% |
37,850
+2,810
| +8% | +$271K |
|
1254
First Hawaiian
FHB
$3.4B
| $3.87M | ﹤0.01% |
149,674
+11,344
| +8% | +$300K |
|
1255
Darling Ingredients
DAR
$9.48B
| $3.87M | ﹤0.01% |
194,663
+17,389
| +10% | +$357K |
|
1256
B2Gold
BTG
$5.49B
| $3.87M | ﹤0.01% |
1,270,077
+167,780
| +15% | +$459K |
|
1257
Dana Inc
DAN
$3.23B
| $3.87M | ﹤0.01% |
193,918
+13,100
| +7% | +$233K |
|
1258
Trex
TREX
$4.94B
| $3.85M | ﹤0.01% |
107,392
+6,576
| +7% | +$223K |
|
1259
United Bankshares
UBSI
$6.73B
| $3.85M | ﹤0.01% |
103,667
+4,453
| +4% | +$167K |
|
1260
FirstCash
FCFS
$8.87B
| $3.84M | ﹤0.01% |
38,441
+2,830
| +8% | +$269K |
|
|
TGNA
1261
DELISTED
TEGNA Inc
TGNA
| $3.84M | ﹤0.01% |
253,778
+28,973
| +13% | +$446K |
|
1262
Emergent Biosolutions
EBS
$288M
| $3.82M | ﹤0.01% |
79,159
+27,813
| +54% | +$1.33M |
|
1263
ATI
ATI
$32.2B
| $3.82M | ﹤0.01% |
151,721
+18,948
| +14% | +$462K |
|
1264
NIO
NIO
$11.5B
| $3.81M | ﹤0.01% |
1,495,840
+1,472,640
| +6,348% | +$5.91M |
|
1265
Genpact
G
$5.98B
| $3.81M | ﹤0.01% |
100,084
+12,050
| +14% | +$438K |
|
1266
Nutanix
NTNX
$16.1B
| $3.81M | ﹤0.01% |
146,714
+15,001
| +11% | +$523K |
|
1267
Louisiana-Pacific
LPX
$5.32B
| $3.78M | ﹤0.01% |
144,265
+11,193
| +8% | +$274K |
|
1268
Keurig Dr Pepper
KDP
$42.2B
| $3.78M | ﹤0.01% |
130,847
+19,248
| +17% | +$548K |
|
1269
Sprouts Farmers Market
SFM
$7.83B
| $3.78M | ﹤0.01% |
200,112
+16,039
| +9% | +$334K |
|
|
CMD
1270
DELISTED
Cantel Medical Corporation
CMD
| $3.75M | ﹤0.01% |
46,494
+3,713
| +9% | +$261K |
|
1271
Avista
AVA
$3.26B
| $3.75M | ﹤0.01% |
84,031
+533
| +0.6% | +$22.7K |
|
1272
CoreCivic
CXW
$3.08B
| $3.75M | ﹤0.01% |
180,490
+14,433
| +9% | +$311K |
|
|
MFGP
1273
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $3.74M | ﹤0.01% |
142,717
-3,396
| -2% | -$89.7K |
|
1274
HealthEquity
HQY
$8.68B
| $3.73M | ﹤0.01% |
57,091
-295,213
| -84% | -$20.5M |
|
1275
Cabot Corp
CBT
$4.39B
| $3.72M | ﹤0.01% |
78,075
-8,087
| -9% | -$364K |
|
Similar funds
UBS AM's Q2 2019 Portfolio in Review
As of Q2 2019, UBS AM held 2,924 positions worth $140B, up 4% from $135B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS AM's Q2 2019 filing shows 135 new, 1,612 increased, 794 reduced and 70 closed positions. Its largest new stake was Dow Inc: 2,393,505 shares worth $118M. The largest sale was Microsoft, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2019 buy was Dow Inc: 2,393,505 shares worth $118M.
- UBS AM added most to Alibaba in Q2 2019, an estimated $365M increase.
- UBS AM's biggest Q2 2019 reduction was Microsoft, cutting an estimated $210M.
- UBS AM fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $18.2M.
- UBS AM's ten largest holdings make up 18% of its $140B portfolio in Q2 2019.
- UBS AM opened 135 new positions and closed 70 in Q2 2019.
- UBS AM's portfolio value rose 4% quarter-over-quarter to $140B.
Based on UBS AM's 13F filing for Q2 2019, filed 15 Aug 2019.